We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+15.46%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.97B
AUM Growth
+$823M
Cap. Flow
+$400M
Cap. Flow %
8.04%
Top 10 Hldgs %
46.77%
Holding
94
New
22
Increased
21
Reduced
16
Closed
33

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$384M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$238M
3
AGN
Allergan plc
AGN
+$175M
4
MDVN
MEDIVATION, INC.
MDVN
+$122M
5
AMZN icon
Amazon
AMZN
+$105M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$174M
2
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
+$106M
3
GILD icon
Gilead Sciences
GILD
+$106M
4
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
+$104M
5
DG icon
Dollar General
DG
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 39.81%
2 Communication Services 12%
3 Real Estate 9.46%
4 Energy 7.24%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$125B
$400M 8.05%
+7,532,007
New +$384M
GILD icon
2
Gilead Sciences
GILD
$163B
$271M 5.46%
3,614,168
-1,516,783
-30% -$106M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.23T
$263M 5.28%
+9,414,717
New +$238M
HOT
4
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$248M 5%
3,127,673
-46,462
-1% -$3.4M
A icon
5
Agilent Technologies
A
$38B
$236M 4.74%
5,764,510
+732,827
+15% +$27.9M
AMZN icon
6
Amazon
AMZN
$2.62T
$206M 4.14%
10,332,780
+5,834,940
+130% +$105M
AGN
7
DELISTED
Allergan plc
AGN
$199M 4.01%
1,186,035
+1,119,376
+1,679% +$175M
MDVN
8
DELISTED
MEDIVATION, INC.
MDVN
$174M 3.49%
5,439,718
+4,041,270
+289% +$122M
HCA icon
9
HCA Healthcare
HCA
$82.9B
$171M 3.43%
3,578,005
+908,581
+34% +$42M
PCP
10
DELISTED
PRECISION CASTPARTS CORP
PCP
$158M 3.18%
587,767
+355,700
+153% +$89.5M
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
$156M 3.13%
2,583,508
+556,600
+27% +$30.3M
TNL icon
12
Travel + Leisure Co
TNL
$4.72B
$136M 2.72%
4,073,008
-2,322,246
-36% -$71.1M
ETN icon
13
Eaton
ETN
$159B
$123M 2.48%
1,620,644
-894,063
-36% -$63.6M
VLO icon
14
Valero Energy
VLO
$92.8B
$120M 2.41%
+2,380,911
New +$100M
AMT icon
15
American Tower
AMT
$77.1B
$119M 2.38%
1,485,052
+305,635
+26% +$23.7M
ANDV
16
DELISTED
Andeavor
ANDV
$117M 2.36%
+2,005,206
New +$104M
META icon
17
Meta Platforms (Facebook)
META
$1.6T
$111M 2.24%
+2,037,334
New +$102M
ADBE icon
18
Adobe
ADBE
$88.2B
$111M 2.23%
1,849,097
-193,250
-9% -$10.7M
CCI icon
19
Crown Castle
CCI
$33.7B
$104M 2.08%
+1,411,872
New +$104M
CRM icon
20
Salesforce
CRM
$134B
$97.4M 1.96%
1,764,597
+30,822
+2% +$1.65M
MDCO
21
DELISTED
Medicines Co
MDCO
$81.7M 1.64%
2,116,102
-248,999
-11% -$8.9M
TWX
22
DELISTED
Time Warner Inc
TWX
$80.5M 1.62%
1,204,882
-971,700
-45% -$62.8M
ENDP
23
DELISTED
Endo International plc
ENDP
$79.5M 1.6%
+1,178,973
New +$67.3M
DG icon
24
Dollar General
DG
$26.8B
$78.6M 1.58%
1,303,447
-1,761,112
-57% -$103M
CMI icon
25
Cummins
CMI
$92.2B
$73.7M 1.48%
522,514
-741,474
-59% -$98.4M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q4 2013 Portfolio in Review

As of Q4 2013, PFM Health Sciences held 94 positions worth $4.97B, up 20% from $4.15B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

PFM Health Sciences deployed $400M of net new capital in Q4 2013, opening 22 new positions and adding to 21 existing holdings. Its largest new stake was Bristol-Myers Squibb: 7,532,007 shares worth $400M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 34% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $174M trimmed.

  • PFM Health Sciences's largest Q4 2013 buy was Bristol-Myers Squibb: 7,532,007 shares worth $400M.
  • PFM Health Sciences added most to Allergan plc in Q4 2013, an estimated $175M increase.
  • PFM Health Sciences's biggest Q4 2013 reduction was Thermo Fisher Scientific, cutting an estimated $174M.
  • PFM Health Sciences fully exited CAMERON INTERNATIONAL CORPORATION in Q4 2013, selling an estimated $106M.
  • PFM Health Sciences's ten largest holdings make up 47% of its $4.97B portfolio in Q4 2013.
  • PFM Health Sciences opened 22 new positions and closed 33 in Q4 2013.
  • PFM Health Sciences's portfolio value rose 20% quarter-over-quarter to $4.97B.

Based on PFM Health Sciences's 13F filing for Q4 2013, filed 14 Feb 2014.